Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/1999
10/21/1999WO1999053287A2 Electronic techniques for analyte detection
10/21/1999WO1999053273A1 Gas meter incorporating calorific measurement
10/21/1999WO1999053103A1 Diagnosis of multiple sclerosis and other demyelinating diseases
10/21/1999WO1999053099A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999WO1999053094A1 Method for in vivo detecting target protein gene by drug
10/21/1999WO1999053093A1 Method for carrying out reactions between at least two reaction partners in aqueous reaction mixtures
10/21/1999WO1999053092A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/21/1999WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999WO1999053058A1 Vertebrate patched-2 protein
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999053054A1 Axor4 g-protein-coupled receptor
10/21/1999WO1999053051A2 5' ests and encoded human proteins
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053038A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/21/1999WO1999053028A1 Pns cell lines and methods of use therefor
10/21/1999WO1999053024A1 Methods to identify compounds affecting mitochondria
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052945A2 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
10/21/1999WO1999052944A1 G-protein coupled receptors
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052924A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999WO1999052877A1 Receptor ligands
10/21/1999WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis
10/21/1999WO1999052708A1 Liquid labeling with fluorescent microparticles
10/21/1999WO1999052551A1 Therapy of atherosclerosis
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052370A1 Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent
10/21/1999WO1999045119A3 Production of mycobacterial polypeptides by lactic acid bacteria
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999040114A9 Novel gabab receptor dna sequences
10/21/1999WO1999039298A9 Point of care diagnostic systems
10/21/1999WO1999038980A9 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1999024607A3 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI)
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999WO1999014378A3 Methods using interleukin 4 to treat hiv infection
10/21/1999WO1999009416A3 Method of drug selection
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817921A1 New mycobacterial mutants used to screen for antibiotic vectors
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19817531A1 Sequential synthesis or analysis involving multiple positions on flat substrate
10/21/1999DE19817180A1 Biosensor, especially for surface plasmon resonance, with surface comprising noble metal film bound to hydrogel via monolayer of organic molecules
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999DE19751706C2 Vorrichtung und Verfahren zum Nachweis von Analyten Apparatus and method for detecting analytes
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2328881A1 Expert system for analysis of dna sequencing electropherograms
10/21/1999CA2328616A1 Methods for disease diagnosis from stool samples
10/21/1999CA2328302A1 Method for fixing a biological molecule on a support surface
10/21/1999CA2328252A1 Receptor ligands
10/21/1999CA2328249A1 Real time detection of antigens
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2327169A1 Solid phase test for endotoxin
10/21/1999CA2326717A1 Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325603A1 Pns cell lines and methods of use therefor
10/21/1999CA2325602A1 Regulated target expression for screening
10/21/1999CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999CA2325576A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999CA2325565A1 Diagnosis of multiple sclerosis and other demyelinating diseases
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999CA2323107A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999CA2319089A1 5' ests and encoded human proteins
10/20/1999EP0950895A2 Sensors arrays for detecting analytes in fluids
10/20/1999EP0950718A1 Method for detecting dna with probe pna
10/20/1999EP0950717A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/20/1999EP0950710A2 Cells expressing a chimera receptor and their uses
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950188A1 Ouabain immunoassay and kit and ouabain labeled with i125 or fluorescent label
10/20/1999EP0950187A1 Characterization of fluid misting
10/20/1999EP0950185A1 Micro systems for biological analyses, their use for detecting analytes and method for producing them
10/20/1999EP0950184A1 High-throughput screening method and apparatus
10/20/1999EP0950178A1 Apparatus and method for measuring the quality of concrete
10/20/1999EP0950114A1 Encoding of organometallic libraries
10/20/1999EP0950112A1 Photolabile polymer array synthesis methods
10/20/1999EP0950108A1 Streptococcus pneumoniae dna sequences
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999EP0950095A2 TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
10/20/1999EP0950062A1 Protein markers for esophageal cancer
10/20/1999EP0950061A1 Heat shock protein complexes
10/20/1999EP0871861A4 Optical trap for detection and quantitations of subzeptomolar quantities of analytes
10/20/1999EP0769065A4 Methods for identifying inhibitors of integrin activation
10/20/1999EP0760103B1 Solid-phase filtration method for antigen and antibody assays in bloodgroup serology, and test kit
10/20/1999EP0663958A4 Inhibition of cyst formation by cytoskeletal specific drugs.
10/20/1999EP0646215B1 Method and apparatus for pressure, volume, and temperature measurement and characterization of subsurface formations
10/20/1999EP0641443B1 Quantitative clotting assay for activated factor vii
10/20/1999EP0635006B1 Europium and terbium chelators for time-resolved fluorometric assays
1 ... 3179 3180 3181 3182 3183 3184 3185 3186 3187 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 ... 3937